Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Income Statement Business | Product | Geographic

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsMar-31-23Dec-31-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21
   8-K8-K10-Q10-Q10-K10-Q10-Q10-Q
Total revenues   [+]2,374.82,302.72,196.22,097.52,072.61,984.21,793.41,724.3
            Revenue growth  13.2%11.1%22.5%21.6%27.3%29.0%17.6%13.8%
Cost of goods sold  266.9283.3261.8245.8247.4236.5228.0192.3
Gross profit  2,107.92,019.41,934.41,851.71,825.21,747.71,565.41,532.0
            Gross margin  88.8%87.7%88.1%88.3%88.1%88.1%87.3%88.8%
Selling, general and administrative   [+]241.1267.4215.3215.2255.2198.2194.6192.1
Research and development  742.6694.1600.1603.1694.3493.8448.7456.0
EBITDA   [+]  1,156.31,069.3909.61,087.4953.4912.7
            EBITDA margin  47.3%45.9%52.7%51.0%43.9%54.8%53.2%52.9%
Depreciation and amortization    37.335.933.831.731.328.8
EBIT   [+]1,124.21,057.91,119.01,033.4875.71,055.7922.1883.9
            EBIT margin  47.3%45.9%51.0%49.3%42.3%53.2%51.4%51.3%
Non-recurring items  345.224.412.7-7.5-2.01.2960.0-3.9
Interest expense, net   [+] -74.414.614.915.115.315.515.7
Other income (expense), net   [+]112.5-31.1-67.3-71.28.343.59.2-51.2
Pre-tax income  891.51,076.81,024.4954.8871.01,082.7-44.2820.9
Income taxes  191.7257.9213.9192.7100.8230.8-111.2167.8
            Tax rate  21.5%24.0%20.9%20.2%11.6%21.3%251.6%20.4%
Net income  699.8818.9810.5762.1770.1851.967.0653.1
            Net margin  29.5%35.6%36.9%36.3%37.2%42.9%3.7%37.9%
   
Basic EPS   [+]$2.72$3.19$3.17$2.99$2.99$3.30$0.26$2.52
Diluted EPS   [+]$2.69$3.15$3.13$2.96$2.96$3.28$0.26$2.49
   
Shares outstanding (basic)   [+]257.4256.9255.9255.1257.7257.9259.0259.4
Shares outstanding (diluted)   [+]260.3260.3258.7257.9259.9259.7261.0261.9
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy